TYLIGAND BIOSCIENCE
Tyligand Bioscience is a biotechnology company that focuses on the discovery and development of small molecule therapeutics to help patients with cancer and autoimmune diseases. Tyligand's pharmaceuticals are designed to target and treat tumors and autoimmune disorders, enabling healthcare professionals to prescribe more effective medicine and improve health outcomes.
TYLIGAND BIOSCIENCE
Industry:
Biotechnology Health Care Medical
Founded:
2018-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.tyligand.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Euro SPF IPv6 Cloudflare Hosting Japanese Yen Cloudflare DNS
Similar Organizations
AI Medic
AI Medic develops medical technology that automates segmentation of coronary arteries and the heart based on CT images.
AiPharma
AiPharma is a biopharmaceutical company that develops and commercializes oral therapies for patients with life-threatening viral diseases.
Allgenesis Biotherapeutics
Allgenesis Biotherapeutics is a clinical-stage ophthalmology company that develops small molecules and biologics for ophthalmic diseases.
Amtix Bio
Amtix Bio is a biotechnology company that develops drugs to treat microbial infectious diseases and related diseases.
Jixing Pharmaceuticals
Jixing Pharmaceuticals develops innovative science and medicines to underserved Chinese patients with serious and life-threatening diseases.
New NI Medical
New NI Medical is a biotechnology company that develops and manufactures whole body bioimpedance systems.
PK Biosciences Corporation
PK Bio is a biotechnology company that produces oral medicines for patients with neurodegenerative diseases.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Current Employees Featured
Founder
Investors List
Shengdi Investment
Shengdi Investment investment in Series A - Tyligand Bioscience
YF Capital
YF Capital investment in Series A - Tyligand Bioscience
TaiKun Fund
TaiKun Fund investment in Series A - Tyligand Bioscience
Calor Capital
Calor Capital investment in Series A - Tyligand Bioscience
Ming Bioventures
Ming Bioventures investment in Series A - Tyligand Bioscience
BOHE Angel Fund
BOHE Angel Fund investment in Series A - Tyligand Bioscience
CMS Capital
CMS Capital investment in Series A - Tyligand Bioscience
Med-Fine Capital
Med-Fine Capital investment in Seed Round - Tyligand Bioscience
Official Site Inspections
http://www.tyligand.com
- Host name: 172.67.164.49
- IP address: 172.67.164.49
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Tyligand Bioscience"
Tyligand Bioscience - Crunchbase Company Profile
Tyligand Bioscience is a biotechnology company that focuses on the discovery and development of small molecule therapeutics to help patients with cancer …See details»
Company Profile - Tyligand Bioscience
Tyligand Bioscience was founded in 2018, located in Zhangjiang Medicine Valley in Shanghai Pilot Free Trade Zone. We have an integrated 45,000 ft2 state of the art facility that houses medicinal chemistry, biological testing, ADME …See details»
Tyligand - Products, Competitors, Financials, Employees, …
About Tyligand Bioscience: Founded in 2018, Tyligand Bioscience is a clinical stage biotech focusing on the discovery and development of transformative therapies for cancer. In addition …See details»
Tyligand Bioscience - VentureRadar
Tyligand Bioscience is is focused on the discovery and development of cancer therapeutics to address drug resistant tumors such as NSCLC and TNBC. Leveraging deep insights into the …See details»
Company Profile - Tyligand Bioscience
Tyligand (Shanghai) Bioscience English WebsiteSee details»
Tyligand Company Profile - Office Locations, Competitors ... - Craft
Tyligand Bioscience (泰励生物科技) is a biotechnology company focusing on the development of small molecule therapeutics to help patients with cancer and autoimmune diseases. Its …See details»
Leadership Team - Tyligand Bioscience
Tony received his Ph.D. from Purdue University under the tutelage of Professor Eiichi Negishi (2010 Nobel Prize winner). Prior to founding Tyligand, he has served as the Senior Research Fellow of Small Molecule Design and …See details»
Home - Tyligand Bioscience
Jan 14, 2025 Tyligand Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and Orally Bioavailable KRAS G12D Inhibitor 17 May 2024 3728 Jinke Rd, Building 1, West Wing, 201203, …See details»
主页 - 泰励生物科技（上海）有限公司
Jul 28, 2023 泰励生物 (Tyligand Bioscience) 将在 AACR 2024 上展示已获 FDA IND 批准的 KRAS G12D 抑制剂 TSN1611 临床前研究结果 20 March 2024 泰励生物全球首创双功能免疫激动剂TSN222一期临床试验完成首例受试者给药See details»
Tyligand Bioscience - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 8, 2023: Series A - Tyligand …See details»
Tyligand Bioscience 2025 Company Profile: Valuation, …
Tyligand Bioscience General Information Description. Developer of micro and synthetic biochemical pharmaceuticals. The company's pharmaceuticals are designed to target and treat tumors and autoimmune disorders, enabling …See details»
Tyligand Bioscience - Tech Stack, Apps, Patents & Trademarks
Tyligand Bioscience is a biotechnology company that develops small molecule therapeutics for patients with cancer and autoimmune diseases. ... Experience the new Crunchbase, powered …See details»
Tyligand Bioscience Secures Multi-Million Dollar Series A
Jul 8, 2023 Founded in 2018, Tyligand Bioscience is a clinical-stage biotechnology company focused on the development of drugs to treat resistant tumors. Based on the concept of …See details»
Tyligand Bioscience - Overview, News & Similar companies
Founded in 2018, Tyligand Bioscience is a clinical-stage biotechnology company focused on the development of drugs to treat resistant tumors. Based on the concept of creative connection …See details»
Tyligand Bioscience - Contacts, Employees, Board Members
Organization. Tyligand Bioscience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. …See details»
Taili Biotechnology Shanghai Co Ltd. - synapse.zhihuiya.com
About Tyligand, Inc. Tyligand Bioscience is a Shanghai based clinical stage biotech focusing on the discovery and development of novel small molecule therapeutics to help patients with …See details»
Context Therapeutics® and Tyligand Bioscience Reach ONA-XR ...
Aug 25, 2021 PHILADELPHIA, PA & SHANGHAI—August 25, 2021—Context Therapeutics Inc. (the “Company”), a women’s oncology company developing advanced small molecule and …See details»
泰励生物全球首创双功能免疫激动剂TSN222获得中美两地临床试验 …
Feb 16, 2023 About Tyligand Bioscience (Shanghai) Limited. Founded in 2018, Tyligand Bioscience is a clinical-stage biotechnology company focused on the discovery and …See details»
Talent Philosophies - Tyligand Bioscience
At Tyligand we believe integrity, trust and innovation go hand-in-hand. We are always looking for agile learners who understand the value of their work, are not content with the status quo, and …See details»
Emerging Roles of Eosinophils in Bone | Current Osteoporosis …
2 days ago IL-8 facilitates endothelial cell organization into capillary-like tube structures in vitro . NGF enhances angiogenesis in a mouse model of ischemia [ 114 ]. MBP, a cationic protein …See details»